A newly identified genetic eye condition gradually steals peripheral vision and night sight while leaving central vision completely intact for many long decades. The condition stems from a specific variant of the EFEMP1 gene that causes abnormally thick material to accumulate between delicate retinal eye cells.
Researchers now call this condition EFEMP1 associated late onset retinal degeneration because it primarily affects the outer edges of the retina very slowly. Furthermore, scientists can detect major abnormalities in rod photoreceptor function even when retinal tissue still appears structurally intact during standard clinical eye exams.
How Darkness Recovery Reveals the Disease
One critical early warning sign involves unusually slow vision recovery when a person moves from a brightly lit room into very dim darkness. This dark adaptation process relies heavily on rod photoreceptors which are the specialized retinal cells that help humans see clearly in low light.
Dr Artur Cideciyan from the University of Pennsylvania explains that this functional marker reveals disease before photoreceptor cells actually die and disappear completely.
One Gene Creates Two Different Diseases
The investigation originally began with a clinical description of one American family that showed unusual patterns of progressive peripheral vision loss in 1998. Scientists initially suspected a different gene called C1QTNF5 but genetic testing revealed a previously unknown variant in the EFEMP1 gene designated as p.Arg140Trp.
Moreover, a separate EFEMP1 variant called p.Arg345Trp causes a completely different disease that attacks central vision through the macula before affecting peripheral sight. The international research team published their comprehensive findings in JAMA Ophthalmology after studying multiple unrelated families across several different European countries very extensively.
Questions and Answers
Q: How exactly does the EFEMP1 gene variant cause abnormal material buildup between retinal cells that eventually leads to progressive night vision loss?
A: The p.Arg140Trp variant produces abnormal protein deposits that accumulate between retinal cells and gradually disrupt the normal function of rod photoreceptor cells.
Q: Can doctors detect this genetic eye disease early enough to potentially preserve night vision before significant and irreversible retinal cell damage occurs?
A: Yes because researchers can measure rod photoreceptor dark adaptation recovery rates to identify functional abnormalities before any structural retinal damage becomes visible.
Analysis of Broader Implications
Researchers do not yet know how widespread this specific genetic variant is across global populations but they suspect it remains relatively rare overall. However, lessons from rare genetic eye diseases often provide valuable insights into the mechanisms behind much more common retinal conditions like macular degeneration.
Therefore, understanding how EFEMP1 variants damage retinal tissue could eventually help scientists develop targeted treatments for age related macular degeneration and similar conditions.
Frequently Asked Questions
1. What specific symptoms should prompt someone to visit an ophthalmologist for a possible evaluation of this newly identified genetic retinal degeneration condition?
Difficulty seeing at dusk and slow adjustment to darkness and gradual loss of peripheral side vision represent the most common early warning signs.
2. Does this genetic eye disease affect both eyes equally or does it typically progress much faster in one eye than the other?
Current research suggests that this condition generally affects both eyes symmetrically because the underlying genetic mutation influences retinal cells throughout both eyes equally.
3. Can genetic testing confirm whether someone carries the specific EFEMP1 gene variant responsible for this late onset form of retinal degeneration disease?
Genetic testing can identify the p.Arg140Trp variant and help families understand their personal risk of developing this specific form of progressive retinal degeneration.
Conclusion
This groundbreaking research provides critical new hope for early detection of a hidden genetic eye disease that silently destroys night vision over time.
Patients who notice difficulty seeing in dim lighting should consult an ophthalmologist promptly because early functional testing detects retinal changes before cell loss.
Disclaimer: This article provides general health information only and does not constitute professional medical advice so readers should consult qualified healthcare providers for personalized guidance.
